| Year |
Citation |
Score |
| 1999 |
Beyer JM, Browning LD. Transforming an industry in crisis: Charisma, routinization, and supportive cultural leadership Leadership Quarterly. 10: 483-520. DOI: 10.1016/S1048-9843(99)00026-0 |
0.311 |
|
| 1998 |
Browning LD, Beyer JM. The structuring of shared voluntary standards in the U.S. semiconductor industry: Communicating to reach agreement Communication Monographs. 65: 220-243. DOI: 10.1080/03637759809376449 |
0.313 |
|
| 1994 |
Beyer JM, Trice HM. Book Review: Corporate Culture and Organizational Symbolism Journal of Marketing. 58: 125-127. DOI: 10.1177/002224299405800211 |
0.306 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1999 |
Beyer JM. Taming and promoting charisma to change organizations Leadership Quarterly. 10: 307-330. DOI: 10.1016/S1048-9843(99)00019-3 |
0.299 |
|
| 1995 |
Browning LD, Beyer JM, Shetler JC. Building Cooperation in a Competitive Industry: Sematech and the Semiconductor Industry Academy of Management Journal. 38: 113-151. DOI: 10.5465/256730 |
0.296 |
|
| 1992 |
Beyer JM. Metaphors, Misunderstandings, and Mischief: A Commentary Organization Science. 3: 467-474. DOI: 10.1287/Orsc.3.4.467 |
0.283 |
|
| 1999 |
Beyer JM, Nino D. Ethics and Cultures in International Business Journal of Management Inquiry. 8: 287-297. DOI: 10.1177/105649269983006 |
0.278 |
|
| 1995 |
Beyer JM, Chanove RG, Fox WB. The Review Process and the Fates of Manuscripts Submitted to AMJ Academy of Management Journal. 38: 1219-1260. DOI: 10.5465/256856 |
0.27 |
|
| 1997 |
Beyer JM, Ashmos DP, Osborn RN. Contrasts in enacting TQM: Mechanistic vs. organic ideology and implementation Journal of Quality Management. 2: 3-39. DOI: 10.1016/S1084-8568(97)90020-1 |
0.266 |
|
| 1997 |
Beyer JM. Research Utilization Bridging a Cultural Gap between Communities Journal of Management Inquiry. 6: 17-22. DOI: 10.1177/105649269761004 |
0.261 |
|
| 1990 |
Beyer JM. The Moral Dimension: Toward a New Economics Academy of Management Review. 15: 329-331. DOI: 10.5465/Amr.1990.4308162 |
0.247 |
|
| 1997 |
Beyer JM, Chattopadhyay P, George E, Glick WH, ogilvie d, Pugliese D. The Selective Perception of Managers Revisited Academy of Management Journal. 40: 716-737. DOI: 10.5465/257060 |
0.24 |
|
| 1996 |
Wolfe RA, Beyer JM, Blackburn RT, Greenhalgh L, Nayyar PR, Seth A. Rethinking the Tenure Process Journal of Management Inquiry. 5: 221-236. DOI: 10.1177/105649269653006 |
0.205 |
|
| 1999 |
Beyer JM. Two approaches to studying charismatic leadership Leadership Quarterly. 10: 575-588. DOI: 10.1016/S1048-9843(99)00037-5 |
0.202 |
|
| 1978 |
Stevens JM, Beyer JM, Trice HM. Assessing personal, role, and organizational predictors of managerial commitment. Academy of Management Journal. Academy of Management. 21: 380-96. PMID 10246524 DOI: 10.2307/255721 |
0.194 |
|
| 1984 |
Trice HM, Beyer JM. Work-related outcomes of the constructive-confrontation strategy in a job-based alcoholism program. Journal of Studies On Alcohol. 45: 393-404. PMID 6503286 DOI: 10.15288/Jsa.1984.45.393 |
0.101 |
|
| 2002 |
Almer LS, Shortridge VD, Nilius AM, Beyer JM, Soni NB, Bui MH, Stone GG, Flamm RK. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 43: 225-32. PMID 12106956 |
0.066 |
|
| 2013 |
Krueger AC, Randolph JT, DeGoey DA, Donner PL, Flentge CA, Hutchinson DK, Liu D, Motter CE, Rockway TW, Wagner R, Beno DW, Koev G, Lim HB, Beyer JM, Mondal R, et al. Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif. Bioorganic & Medicinal Chemistry Letters. 23: 3487-90. PMID 23664214 DOI: 10.1016/j.bmcl.2013.04.057 |
0.063 |
|
| 1981 |
Trice HM, Beyer JM. A data-based examination of selection-bias in the evaluation of a job-based alcoholism program. Alcoholism, Clinical and Experimental Research. 5: 489-96. PMID 7030105 |
0.051 |
|
| 2008 |
Rosch JW, Vega LA, Beyer JM, Lin A, Caparon MG. The signal recognition particle pathway is required for virulence in Streptococcus pyogenes. Infection and Immunity. 76: 2612-9. PMID 18411293 DOI: 10.1128/Iai.00239-07 |
0.047 |
|
| 1985 |
Beyer JM, Hørslev-Petersen K, Helin P. Shuttle case records: link between general practice and the specialist unit. British Medical Journal (Clinical Research Ed.). 290: 677-80. PMID 3918714 |
0.045 |
|
| 1978 |
Trice HM, Beyer JM, Hunt RE. Evaluating implementation of a job-based alcoholism policy. Journal of Studies On Alcohol. 39: 448-65. PMID 651356 DOI: 10.15288/Jsa.1978.39.448 |
0.044 |
|
| 2003 |
Nilius AM, Shen LL, Hensey-Rudloff D, Almer LS, Beyer JM, Balli DJ, Cai Y, Flamm RK. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy. 47: 3260-9. PMID 14506039 |
0.043 |
|
| 2005 |
Omueti KO, Beyer JM, Johnson CM, Lyle EA, Tapping RI. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. The Journal of Biological Chemistry. 280: 36616-25. PMID 16129684 DOI: 10.1074/Jbc.M504320200 |
0.043 |
|
| 1989 |
Beyer JM. Ethical dissent in a new mode: the whistleblowers. Science (New York, N.Y.). 244: 835-6. PMID 17802246 DOI: 10.1126/science.244.4906.835 |
0.041 |
|
| 1988 |
Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides Antimicrobial Agents and Chemotherapy. 32: 1710-1719. PMID 3252753 |
0.037 |
|
| 2002 |
Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. Antimicrobial Agents and Chemotherapy. 46: 783-6. PMID 11850262 |
0.037 |
|
| 1999 |
Shortridge VD, Doern GV, Brueggemann AB, Beyer JM, Flamm RK. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 29: 1186-8. PMID 10524961 DOI: 10.1086/313452 |
0.035 |
|
| 1986 |
Pedersen BK, Beyer JM. A longitudinal study of the influence of azathioprine on natural killer cell activity. Allergy. 41: 286-9. PMID 3752419 |
0.035 |
|
| 1989 |
Antonsen S, Beyer JM. In vitro granulocyte aggregation. Scandinavian Journal of Clinical and Laboratory Investigation. 49: 685-8. PMID 2514455 |
0.035 |
|
| 1988 |
Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. The Journal of Antimicrobial Chemotherapy. 22: 631-6. PMID 3209524 |
0.033 |
|
| 2005 |
Doktor SZ, Beyer JM, Flamm RK, Shortridge VD. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes. Journal of Clinical Microbiology. 43: 150-5. PMID 15634964 DOI: 10.1128/JCM.43.1.150-155.2005 |
0.032 |
|
| 1997 |
Nilius AM, Beyer JM, Flamm RK, Tanaka SK. Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH. Journal of Clinical Microbiology. 35: 1311-5. PMID 9163435 |
0.03 |
|
| 2004 |
Doktor SZ, Shortridge VD, Beyer JM, Flamm RK. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations. Diagnostic Microbiology and Infectious Disease. 49: 47-52. PMID 15135500 DOI: 10.1016/S0732-8893(03)00130-5 |
0.027 |
|
| 1984 |
Pedersen BK, Beyer JM, Rasmussen A, Klarlund K, Pedersen BN, Helin P. Methylprednisolone pulse therapy induced fall in natural killer cell activity in rheumatoid arthritis. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology. 92: 319-23. PMID 6516854 |
0.026 |
|
| 1986 |
Thomsen NH, Hørslev-Petersen K, Beyer JM. Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankylosing spondylitis. European Heart Journal. 7: 240-6. PMID 2423334 |
0.024 |
|
| 1985 |
Pedersen BK, Beyer JM, Klarlund K, Clemmensen IH. Baseline and interferon-enhanced natural killer cell activity in rheumatoid arthritis. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology. 93: 79-84. PMID 2409740 |
0.024 |
|
| 1984 |
Pedersen BK, Beyer JM, Rasmussen A, Klarlund K, Hørslev-Petersen K, Pedersen BN, Helin P. Azathioprine as single drug in the treatment of rheumatoid arthritis induces complete suppression of natural killer cell activity. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology. 92: 221-5. PMID 6507107 |
0.022 |
|
| 1986 |
Pedersen BK, Beyer JM. Characterization of the in vitro effects of glucocorticosteroids on NK cell activity. Allergy. 41: 220-4. PMID 2424334 |
0.019 |
|
| 1985 |
Beyer JM, Hørslev-Petersen K, Helin P. [Methylprednisolone pulse therapy in Felty's syndrome]. Ugeskrift For Laeger. 147: 1774-5. PMID 4024324 |
0.015 |
|
| 1977 |
Trice HM, Beyer JM. A sociological property of drugs: acceptance of users of alcohol and other drugs among university undergraduates. Journal of Studies On Alcohol. 38: 58-74. PMID 834054 |
0.014 |
|
| 1984 |
Beyer JM, Pedersen BK, Hørslev-Petersen K, Helin P. [Polyarthritis associated with hyperlipoproteinemia type II]. Ugeskrift For Laeger. 146: 1559-61. PMID 6506244 |
0.01 |
|
| 1983 |
Hørslev-Petersen K, Beyer JM, Helin P. Intermittent cyclophosphamide in refractory rheumatoid arthritis. British Medical Journal (Clinical Research Ed.). 287: 711-2. PMID 6412793 |
0.01 |
|
| Hide low-probability matches. |